Ion Channels: New Actors Playing in Chemotherapeutic Resistance

In the battle against cancer cells, therapeutic modalities are drastically limited by intrinsic or acquired drug resistance. Resistance to therapy is not only common, but expected: if systemic agents used for cancer treatment are usually active at the beginning of therapy (i.e., 90% of primary breas...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cancers (Basel)
Glavni autori: Kischel, Philippe, Girault, Alban, Rodat-Despoix, Lise, Chamlali, Mohamed, Radoslavova, Silviya, Abou Daya, Hiba, Lefebvre, Thibaut, Foulon, Arthur, Rybarczyk, Pierre, Hague, Frédéric, Dhennin-Duthille, Isabelle, Gautier, Mathieu, Ouadid-Ahidouch, Halima
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2019
Teme:
Review
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6468599/
https://ncbi.nlm.nih.gov/pubmed/30884858
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11030376
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items